期刊文献+

高效液相色谱-串联质谱法测定血浆中熊去氧胆酸的浓度

Determination of ursodeoxycholic acid in human plasma by liquid chromatography tandem mass spectrometry
下载PDF
导出
摘要 目的:建立高效液相色谱-质谱联用的方法测定人血浆内的熊去氧胆酸浓度的方法。方法:采用Shimadzu VP-ODS(4.6 mm×150 mm,5μm)色谱柱;柱温25℃;流动相为(A)乙腈-水(含5 mmol·L^(-1)的乙酸铵)(35:65,V/V),(B)乙情;梯度程序为0~2min,A:B=94:6;2~4.5min,A:B= 80:20:4.5~7min,A:B=94:6;流速为1.0 mL·min^(-1);通过液相串联质谱,电喷雾离子源(ESI),以选择反应监测(SRM)方式进行检测;离子极性监测负离子(-);检测离子为熊去氧胆酸m/z 391.1 [M-H]^-→391.1[M-H]^-,盐酸西替利嗪(内标)m/z 387.1[M-H]^-→387.1[M-H]^-。结果:熊去氧胆酸的最低定量限为40.144μg·L^(-1),线性范围为40.14~12 043μg·L^(-1)(r=0.995)。结论:该方法简便、灵敏度高,可以用来进行熊去氧胆酸的人体药动学和生物等效性研究。 AIM: To develope a high-performance liquid chromatographic tandem mass spectrometric method for the determination of ursodexycholic acid (UDCA) in human plasma. METHODS: Shimadzu VP-ODS (4.6 mm×150 mm, 5μm) chromatographic column was used with 25 ℃ column temperature. The mobile phase consisted of A: acetonitrile/5 mmol·L^-1 ammonium acetate (35 : 65, V/V) and B: acetonitrile at a flowrate of 1.0mL·min^-1, with gradient procedure: 0-2min, A:B=94:6; 2-4.5min, A:B=80:20; 4.5- 7 min, A : B = 94 : 6. A Finnigan TSQ tandem mass spectrometer equipped with electronic spray ionization source was used as detector and operated in the negative ion mode and selected reaction monitoring (SRM). The ion of UDCA to detect was m/z 391.1 [M-H]^-→391.1 [M-H]^-, and the cetirizine ion (internal standard) was m/z 386.9 [M-H]^-→386.9 [M-H]^-. RESULTS: The lower limit of qualification was 40.144μg·L^-1. The standard curve was in linear over a working range of 40.14 - 12 043μg·L^-1 with an standard correlation coefficient of 0.995. CONCLUSION: This method is and bioequivalence studies. simple, sensitive, and suitable for clinical pharmacokinetics
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2006年第8期575-578,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 熊去氧胆酸 血浆 色谱法 高压液相 光谱法 质量 电喷雾电离 ursodeoxycholic acid plasma chromatography, high pressure liquid spectrometry, mass,electrospray ionization
  • 相关文献

参考文献5

  • 1TRAUNER M, GRAZIADEI IW. Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases [J]. Aliment Phamacol Ther, 1999, 13(8) : 979-995.
  • 2韩国庆,吕敏和,孟玫,刘慧.熊去氧胆酸选择性诱导人肝肿瘤细胞凋亡及抑制增殖的实验研究[J].中国新药与临床杂志,2005,24(3):192-196. 被引量:6
  • 3NOBILIS M, POUR M, KUNES J, et ol. High-performance liquid chromatographic determination of ursodeoxycholic acid after solid phase extraction of blood serum and detection-oriented derivatization [J]. J Pharm Biomed Anal, 2001, 24 (5-6) :937-946.
  • 4TESSIER E, NEIRINCK L, ZHU Z. High-performance liquid chromatographic mass spectrometric method for the determination of ursodeoxycholic acid and its glycine and taurine conjugates in human plasma[J]. J Chromatogr Technol Biomed Life Sci B,2003, 798 (2): 295-302.
  • 5SUNDD SINGH S, SHAH H, GUPTA S, et al. Validation of LC/MS electrospray ionisation method for the estimation of ursodiol in human plasma and its application in bioequivalence study[J]. Ann Chim, 2004, 94 (12): 951-959.

二级参考文献6

  • 1WALI RK, STOIBER D, NGUYEN L, et al. Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development[ J]. Cancer Epidemiol Biomarkers Prev, 2002 ,11(11) :1316-1321.
  • 2IM EO, CHOI YH, PAIK KJ, et al. Novel bile acid derivatives induce apoptosis via a p53-independent pathway in human breast carcinoma cells[J]. Cancer Lett, 2001,163(1) :83-93.
  • 3OYAMA K, SHIOTA G, ITO H, et al. Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats [J]. Carcinogenesis, 2002,23(5) :885-892.
  • 4ARAFAT WO, GOMEZ-NAVARRO J, XIANG J, et al. An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer [J]. Mol Ther, 2000, 1(6) :545-554.
  • 5HOTCHKISS RS, SWANSON PE, KNUDSON CM, et al. Overexpression of bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis[J]. J Immunol, 1999,162(7) :4148-4156.
  • 6谢青,李光明,周霞秋,廖丹,俞红,郭清.牛磺酸熊脱氧胆酸对细胞色素C介导HepG2细胞凋亡的作用[J].中华肝脏病杂志,2003,11(5):298-301. 被引量:7

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部